Potential therapeutic strategies for skeletal muscle atrophy

L Huang, M Li, C Deng, J Qiu, K Wang, M Chang… - Antioxidants, 2022 - mdpi.com
The maintenance of muscle homeostasis is vital for life and health. Skeletal muscle atrophy
not only seriously reduces people's quality of life and increases morbidity and mortality, but …

Ubiquitin ligases at the heart of skeletal muscle atrophy control

D Peris-Moreno, L Cussonneau, L Combaret, C Polge… - Molecules, 2021 - mdpi.com
Skeletal muscle loss is a detrimental side-effect of numerous chronic diseases that
dramatically increases mortality and morbidity. The alteration of protein homeostasis is …

Cyclic nucleotide phosphodiesterases: New targets in the metabolic syndrome?

C Lugnier, A Meyer, S Talha, B Geny - Pharmacology & therapeutics, 2020 - Elsevier
Metabolic diseases have a tremendous impact on human morbidity and mortality. Numerous
targets regulating adenosine monophosphate kinase (AMPK) have been identified for …

Long acting GLP-1 analog liraglutide ameliorates skeletal muscle atrophy in rodents

AA Gurjar, S Kushwaha, S Chattopadhyay, N Das… - Metabolism, 2020 - Elsevier
Background Skeletal muscle atrophy is characterized by muscle wasting with partial or
complete functional loss. Skeletal muscle atrophy severely affects the quality of life and …

Perfluorooctane sulfonate-induced oxidative stress contributes to pancreatic β-cell apoptosis by inhibiting cyclic adenosine monophosphate pathway: Prevention by …

S Elumalai, U Karunakaran, KC Won, SM Chung… - Environmental …, 2023 - Elsevier
Endocrine-disrupting chemical perfluorooctane sulfonate (PFOS) acute exposure stimulates
insulin secretion from pancreatic β-cells. However, chronic exposure to PFOS on pancreatic …

Transcriptome analysis suggests the roles of long intergenic non-coding RNAs in the growth performance of weaned piglets

L Chen, G Shi, G Chen, J Li, M Li, C Zou, C Fang… - Frontiers in …, 2019 - frontiersin.org
Long intergenic non-coding RNAs (lincRNAs) have been considered to play a key
regulatory role in various biological processes. An increasing number of studies have …

Phosphodiesterase 4 inhibition restrains muscle proteolysis in diabetic rats by activating PKA and EPAC/Akt effectors and inhibiting FoxO factors

CA Arcaro, RP Assis, JO Oliveira, NM Zanon… - Life Sciences, 2021 - Elsevier
Aim There is growing evidence about the ability of cyclic adenosine monophosphate (cAMP)
signaling and nonselective phosphodiesterase (PDE) inhibitors on mitigate muscle atrophy …

Pentoxifylline-induced protein expression change in RAW 264.7 cells as determined by immunoprecipitation-based high performance liquid chromatography

MH Seo, DW Kim, YS Kim, SK Lee - Plos one, 2022 - journals.plos.org
Although pentoxifylline (PTX) was identified as a competitive non-selective
phosphodiesterase inhibitor, its pharmacological effect has not been clearly elucidated. The …

Drugs for the treatment of muscle atrophy

L Chen, H Zhang, M Chi, Q Yang… - … and management of …, 2021 - books.google.com
Muscle mass is maintained through an interplay between anabolic and catabolic pathways.
The ubiquitin-proteasome system plays an important role in the proteolysis progress during …

Effects of HuoxueJiangtang decoction alone or in combination with metformin on renal function and renal cortical mRNA expression in diabetic nephropathy rats

X Liu, D Liu, Y Shuai, H Li, H Zhao, X Qu… - Pharmaceutical …, 2020 - Taylor & Francis
Context HuoxueJiangtang decoction (ZY) is a traditional Chinese medicine for the treatment
of diabetes. Objective The protective effect of ZY on renal injury in diabetic nephropathy rats …